Literature DB >> 29375191

Nepafenac.

.   

Abstract

Entities:  

Year:  2017        PMID: 29375191      PMCID: PMC5768593          DOI: 10.18773/austprescr.2017.071

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  1 in total

1.  Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.

Authors:  Satish S Modi; Robert P Lehmann; Thomas R Walters; Raymond Fong; William C Christie; Lawrence Roel; David Nethery; Dana Sager; Alexis Tsorbatzoglou; Bo Philipson; Carlo E Traverso; Harvey Reiser
Journal:  J Cataract Refract Surg       Date:  2013-12-15       Impact factor: 3.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.